Need for Multiple Risk Reduction Strategies in Clinical Trials Enrolling High Risk Patients - FOURIER Investigating PCSK-9 Inhibitor to Lower Cholesterol Revisited
Blood Pressure - United Kingdom
doi 10.1080/08037051.2019.1614278
Full Text
Open PDFAbstract
Available in full text
Date
May 4, 2019
Authors
Publisher
Informa UK Limited